JP2015518873A5 - - Google Patents

Download PDF

Info

Publication number
JP2015518873A5
JP2015518873A5 JP2015515528A JP2015515528A JP2015518873A5 JP 2015518873 A5 JP2015518873 A5 JP 2015518873A5 JP 2015515528 A JP2015515528 A JP 2015515528A JP 2015515528 A JP2015515528 A JP 2015515528A JP 2015518873 A5 JP2015518873 A5 JP 2015518873A5
Authority
JP
Japan
Prior art keywords
composition
composition according
weight
hours
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2015515528A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015518873A (ja
Filing date
Publication date
Priority claimed from EP12290189.5A external-priority patent/EP2705835A1/en
Application filed filed Critical
Publication of JP2015518873A publication Critical patent/JP2015518873A/ja
Publication of JP2015518873A5 publication Critical patent/JP2015518873A5/ja
Abandoned legal-status Critical Current

Links

JP2015515528A 2012-06-08 2013-06-06 調節された放出をもたらす可溶性の且つ活性の医薬的成分の水性ゲル化組成物 Abandoned JP2015518873A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12290189.5 2012-06-08
EP12290189.5A EP2705835A1 (en) 2012-06-08 2012-06-08 Aqueous gelling compositions of soluble active pharmaceutical peptides providing modified release
PCT/EP2013/061732 WO2013182653A1 (en) 2012-06-08 2013-06-06 Aqueous gelling compositions of soluble active pharmaceutical peptides providing modified release

Publications (2)

Publication Number Publication Date
JP2015518873A JP2015518873A (ja) 2015-07-06
JP2015518873A5 true JP2015518873A5 (enExample) 2016-07-14

Family

ID=48577065

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015515528A Abandoned JP2015518873A (ja) 2012-06-08 2013-06-06 調節された放出をもたらす可溶性の且つ活性の医薬的成分の水性ゲル化組成物

Country Status (7)

Country Link
US (2) US20150157719A1 (enExample)
EP (2) EP2705835A1 (enExample)
JP (1) JP2015518873A (enExample)
CN (1) CN104487049A (enExample)
HK (1) HK1208171A1 (enExample)
RU (1) RU2014153760A (enExample)
WO (1) WO2013182653A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3301962A1 (en) 2011-12-29 2026-03-02 Rhythm Pharmaceuticals, Inc. Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers
US10196425B2 (en) 2013-03-15 2019-02-05 Rhythm Pharmaceuticals, Inc. Peptide compositions
PT2970389T (pt) 2013-03-15 2020-10-21 Rhythm Pharmaceuticals Inc Composições farmacêuticas

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI331922B (en) * 2002-08-09 2010-10-21 Ipsen Pharma Sas Growth hormone releasing peptides
KR100997177B1 (ko) 2005-07-08 2010-11-29 입센 파마 에스.에이.에스 멜라노코르틴 수용체 리간드
CA2665101A1 (en) * 2006-10-05 2008-04-10 Panacea Biotec Ltd. Injectable depot composition and it's process of preparation
EP2148692B1 (en) 2007-05-25 2017-01-25 Ipsen Pharma S.A.S. Melanocortin receptor ligands modified with hydantoin
TW200916113A (en) * 2007-08-08 2009-04-16 Sod Conseils Rech Applic Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue
WO2009120656A1 (en) * 2008-03-24 2009-10-01 Palatin Technologies, Inc. Pharmaceutical for ocular indications
US9314509B2 (en) * 2009-11-16 2016-04-19 Ipsen Pharma S.A.S. Pharmaceutical compositions of melanocortin receptor ligands
BR112013027222B1 (pt) * 2011-06-14 2022-07-12 Ipsen Pharma S.A.S. Composição de liberação sustentada que contém peptídeos como ingrediente ativo

Similar Documents

Publication Publication Date Title
JP2014240439A5 (enExample)
HK1247822A1 (zh) 用於活性剂口服给药的制剂
JP2016513736A5 (enExample)
JP2013523677A5 (enExample)
JP2018021007A5 (enExample)
JP2015527402A5 (enExample)
JP2016515561A5 (enExample)
JP2013525493A5 (enExample)
JP2016510019A5 (enExample)
AR083422A1 (es) Composiciones y metodos para tratar la hipertension pulmonar
JP2010265321A5 (enExample)
MX365657B (es) Composición novedosa y método de uso para controlar patógenos y prevenir enfermedades en semillas.
JP2015511241A5 (enExample)
JP2013507423A5 (enExample)
CO6680640A2 (es) Uso de aglutinantes para fabircar formulaciones estables al almacenamiento
JP2016534153A5 (enExample)
JP2017105862A5 (enExample)
JP2016503058A5 (enExample)
JP2016512210A5 (enExample)
MX2010003923A (es) Formulacion farmaceutica de valsartan.
JP2015517484A5 (enExample)
MX2013006187A (es) Composiciones farmaceuticas.
AR062979A1 (es) Formulaciones orales liofilizadas de desintegracion rapida de un antagonista del receptor de trombina
JP2017532316A5 (enExample)
WO2012020301A3 (en) Oral controlled release pharmaceutical compositions of blonanserin